Efficacy and safety of tofacitinib in patients with ulcerative colitis a prospective national multicenter cohort
Brief description of study
The purpose of this research study is to evaluate the effectiveness and safety of Tofacitinib in patients with ulcerative colitis who are taking it in a standard of care setting. Tofacitinib is an FDA approved drug for the treatment of ulcerative colitis.
Clinical Study Identifier: s19-00191
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
